Yi Chen
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Geriatrics and Gerontology top 1%
Papers in
-
- Circular RNAs in diseases 14
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 10
- Epidemiology 43
- Autophagy in Disease and Therapy 17
- Co-authors
- Bo Liu (12 shared papers)Leilei Fu (3 shared papers)Shiou Zhu (2 shared papers)Minru Liao (2 shared papers)Peng Fu (1 shared paper)Cheng Peng (1 shared paper)Rui Qin (1 shared paper)Bo Han (1 shared paper)
- Journals
- PLoS ONE (10 papers)Journal of Medicinal Chemistry (8 papers)European Journal of Medicinal Chemistry (6 papers)Frontiers in Genetics (4 papers)Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yi Chen
361 papers receiving 9.7k citations
Yi Chen's Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 1.6k
- Geriatrics and Gerontology 201
- Molecular Biology 3.8k
- Hepatology 360
- Oncology 927
Countries citing papers authored by Yi Chen
This map shows the geographic impact of Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chen more than expected).
Fields of papers citing papers by Yi Chen
This network shows the impact of papers produced by Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chen. The network helps show where Yi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 380 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulated cell death (RCD) in cancer: key pathways and targeted therapies Hit paper breakdown → | 2022 | 579 |
| 2 | Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target Hit paper breakdown → | 2020 | 359 |
| 3 | 2016 | 253 | |
| 4 | 2010 | 228 | |
| 5 | 2018 | 215 | |
| 6 | 2018 | 210 | |
| 7 | 2018 | 182 | |
| 8 | 2014 | 172 | |
| 9 | 2014 | 165 | |
| 10 | 2014 | 151 | |
| 11 | 2021 | 138 | |
| 12 | 2020 | 136 | |
| 13 | 2020 | 121 | |
| 14 | 2020 | 121 | |
| 15 | 2010 | 117 | |
| 16 | 2020 | 106 | |
| 17 | 2020 | 105 | |
| 18 | 2018 | 100 | |
| 19 | 2022 | 93 | |
| 20 | 2013 | 88 |
About Yi Chen
Yi Chen is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Surgery and Materials Chemistry, having authored 380 papers that have together received 9.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), MicroRNA in disease regulation (18 papers), Autophagy in Disease and Therapy (17 papers), Circular RNAs in diseases (14 papers), Luminescence and Fluorescent Materials (13 papers), RNA modifications and cancer (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Epigenetics and DNA Methylation (10 papers). The work is most often cited by research in Cancer Research (1.6k citations), Geriatrics and Gerontology (201 citations), Molecular Biology (3.8k citations), Hepatology (360 citations) and Oncology (927 citations). Yi Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Bo Liu, Leilei Fu, Shiou Zhu, Minru Liao, Peng Fu, Cheng Peng, Rui Qin, Bo Han, Liang Ouyang and Rong‐Rong He. Their work appears in journals such as PLoS ONE, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Frontiers in Genetics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.